APPLICATION OF TPK AS A TARGET IN ALZHEIMER'S DISEASE - SHANGHAI RIXIN BIOTECHNOLOGY CO LTD

Title:

APPLICATION OF TPK AS A TARGET IN ALZHEIMER'S DISEASE

Document Type and Number:

WIPO Patent Application WO/2021/023069

Kind Code:

A8

Abstract:

Provided is an application of thiamine pyrophosphokinase TPK as a target in the treatment or prevention of Alzheimer's disease; using TPK as a target, brain TPK protein kinase activity or/and expression levels are promoted, preventing AD symptoms caused by TPK inhibition.

More Like This:

JPWO2020091070	UV-induced inflammation inhibitors including alternative autophagy inducers
JP6039559	The pyrazolo pillage non derivative as a LPA receptor antagonist
JP2022106976	ENGINEERED ANTIBODY COMPOUNDS AND CONJUGATES THEREOF

Inventors:

ZHONG CHUNJIU (CN)
SANG SHAOMING (CN)

Application Number:

PCT/CN2020/105353

Publication Date:

May 14, 2021

Filing Date:

July 29, 2020

Export Citation:

Click for automatic bibliography generation Help

Assignee:

SHANGHAI RIXIN BIOTECHNOLOGY CO LTD (CN)

International Classes:

A61K45/00; A61P25/28; C12N15/11; C12N15/85; C12N15/90

Attorney, Agent or Firm:

UNITALEN ATTORNEYS AT LAW (CN)

Download PDF:

View/Download PDF PDF Help

Previous Patent: METHOD FOR SENDING AND RECEIVING SCHEDULING REQUESTS AND COMMUNICATION APPARATUS

Next Patent: WIRELESS COMMUNICATION TRANSMISSION METHOD, TERMINAL DEVICE AND STORAGE MEDIUM